These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 7508008)

  • 21. Sodium pumps: ouabain, ion transport, and signaling in hypertension.
    Blaustein MP; Hamlyn JM; Pallone TL
    Am J Physiol Renal Physiol; 2007 Jul; 293(1):F438; author reply F439. PubMed ID: 17616574
    [No Abstract]   [Full Text] [Related]  

  • 22. [Endogenous digitalis-like factor].
    Takahashi H; Komiyama Y
    Nihon Rinsho; 2006 Jul; 64 Suppl 5():177-81. PubMed ID: 16895183
    [No Abstract]   [Full Text] [Related]  

  • 23. [Effect of natriuretic hormone and changes in the lipid spectrum of erythrocyte membranes on the activity of enzymes of transmembrane ion transport in patients with essential hypertension].
    Gapon LI; Shafer MZh; Velizhanina IA; Zhuravleva TD
    Ter Arkh; 1990; 62(12):40-4. PubMed ID: 1964748
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Natriuretic factors].
    Vantyghem MC; Lefebvre J
    Pathol Biol (Paris); 1987 Apr; 35(4):405-15. PubMed ID: 2954021
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Natriuretic hormone.
    Buckalew VM; Gruber KA
    Annu Rev Physiol; 1984; 46():343-58. PubMed ID: 6324656
    [No Abstract]   [Full Text] [Related]  

  • 26. A Diuretic Specifically Designed for Treating Hypertension: Current Insights. Proceedings of a satellite symposium to the 14th scientific meeting of the International Society of Hypertension. Madrid, Spain, June 19, 1992.
    J Cardiovasc Pharmacol; 1993; 22 Suppl 6():S1-110. PubMed ID: 7508053
    [No Abstract]   [Full Text] [Related]  

  • 27. Cardenolides and bufadienolides as hormones: what is missing?
    Lichtstein D; Rosen H; Dvela M
    Am J Physiol Renal Physiol; 2012 Apr; 302(8):F957-8. PubMed ID: 22301627
    [No Abstract]   [Full Text] [Related]  

  • 28. Vascular effects of altered sodium, potassium pump activity.
    Mulvany MJ
    Scand J Clin Lab Invest Suppl; 1986; 180():40-8. PubMed ID: 3012761
    [No Abstract]   [Full Text] [Related]  

  • 29. The natriuretic hormone.
    de Wardener HE
    Ann Clin Biochem; 1982 May; 19(3):137-40. PubMed ID: 6284013
    [No Abstract]   [Full Text] [Related]  

  • 30. The relation of the natriuretic hormone to essential hypertension.
    de Wardener HE; MacGregor GA
    Postgrad Med J; 1983; 59 Suppl 2():74-7. PubMed ID: 6310538
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Management of Hypertension and Prevention of Cardiac Complications Using Calcium Antagonists. Proceedings of the 1st International Nifedipine GITS Symposium, Cannes, February 28, 1992 and of a satellite symposium to the 14th ISH Congress, Madrid, June 14, 1992.
    J Cardiovasc Pharmacol; 1993; 21 Suppl 2():S1-66. PubMed ID: 7692144
    [No Abstract]   [Full Text] [Related]  

  • 32. [Natriuretic factor (a review of the literature)].
    Shaposhnikov AV; Titov VN; Mikhaĭlovskiĭ N; Likhardus B; Cherniad'eva IF
    Lab Delo; 1986; (11):670-7. PubMed ID: 2432341
    [No Abstract]   [Full Text] [Related]  

  • 33. Symposium on natriuretic factors, sodium, calcium and hypertension. Proceedings of the 11th National Congress of Cardiology. Ancona, Italy.
    Int J Cardiol; 1989; 25 Suppl 1():S1-92. PubMed ID: 2620995
    [No Abstract]   [Full Text] [Related]  

  • 34. Inotropic effects of ouabain and Na, K-ATPase activity in failing rabbit hearts.
    Ezzaher A; Mougenot R; Baggioni A; el Ouazzani T; Crozatier B; Maixent JM
    C R Acad Sci III; 1995 Feb; 318(2):273-9. PubMed ID: 7757817
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Correlation of renal organic anion and cation transport with blood pressure in SHR.
    Gharib N; Gao CY; Areas JL; el Zein M; Preuss HG
    Clin Nephrol; 1991 Aug; 36(2):87-92. PubMed ID: 1657469
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Brain Na+,K+-ATPase isozyme activity and protein expression in ouabain-induced hypertension.
    Kent MA; Huang BS; Van Huysse JW; Leenen FH
    Brain Res; 2004 Aug; 1018(2):171-80. PubMed ID: 15276875
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evidence for a circulating Na,K-pump inhibitor in essential hypertension.
    Hilton PJ
    Scand J Clin Lab Invest Suppl; 1986; 180():65-71. PubMed ID: 3012764
    [No Abstract]   [Full Text] [Related]  

  • 38. [Humoral mechanisms in the pathogenesis of arterial hypertension with emphasis on the renin-angiotensin-aldosterone system and natriuretic substances].
    Horký K
    Vnitr Lek; 1989 Mar; 35(3):219-25. PubMed ID: 2525299
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Uroguanylin modulates (Na++K+)ATPase in a proximal tubule cell line: Interactions among the cGMP/protein kinase G, cAMP/protein kinase A, and mTOR pathways.
    Arnaud-Batista FJ; Peruchetti DB; Abreu TP; do Nascimento NR; Malnic G; Fonteles MC; Caruso-Neves C
    Biochim Biophys Acta; 2016 Jul; 1860(7):1431-8. PubMed ID: 27102282
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Effect of a natriuretic factor of hepatic origin on the indices of water-salt metabolism and blood circulation].
    Konovchuk VN; Ivanov IuI
    Fiziol Zh SSSR Im I M Sechenova; 1989 Feb; 75(2):245-50. PubMed ID: 2542104
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.